Research Article

Erythropoiesis and Iron Homeostasis in Non-Transfusion-Dependent Thalassemia Patients with Extramedullary Hematopoiesis

Table 2

Biomarkers of erythropoiesis and iron metabolism of NTDT patients with and without EMH and normal controls.

ParametersEMH (+)EMH (-)Normalp value

n=26n=26n=26
Hb(g/L)71.5±15.1175±14.68136.96±12.39<0.001
 Hb<605(19.2%)2(7.7%)0.226
 60≤Hb<9015(57.7%)17(65.4%)
 Hb≥906(23.1%)7 (26.9%)
A24.93(1.2-46.8)4(0.5-61.5)2.8 (2.2-3.3)0.003
F22.6(0.2-95.8)25.6(0.1-97.3)0.4 (0.2-1.2)<0.001
Liver Function
 ALT(U/L)26.5(4-80)22(7-65)17(9-28)0.001
 AST(U/L)34(12-122)32(11-119)16.5(7-35)0.001
Serum ferritin(ng/mL)2450.50(13.85-8300.0)★,●1458.0(82.78-6128.0)138.05(30.90-535.7)<0.001
 SF<8007 (26.9%)6 (23.1%)0.017
 800≤SF<25006 (23.1%)16 (61.5%)
 SF≥250013 (50.0%)4 (15.4%)
LIC (mg/g dry tissue)20.05±14.7417.85±12.43NA0.74
 LIC<31(4.8%)1(4.8%)0.760
 3≤LIC<76(25.0%)5(20.8%)
 7≤LIC<155(20.8%)5(20.8%)
 LIC>1512(50.0%)13(54.2%)
Cardiac T2(ms)33.38±15.1831.59±14.33NA0.73
 T2<202(15.3)3 (13.0%)0.846
 T2≥2011(84.6%)20 (87.0%)
Hepcidin ( ng/mL)30.47(0.66-154.3)22.06(1.0-130.67)112.38(31.50-170.40)<0.001
EPO( mIU/mL)30.0(6.66-114.36)★,●40.62(10.03-13472.0)5.85(3.5-29.40)<0.001
GDF-15( pg/mL)9428.32(536.28-38660.57)★,●3097.8(6.95-34298.90)176.02(58.57-953.62)<0.001
STfR( mg/L)8.15 (2.42-8.47)8.07 (3.07-9.87)2.63 (0.32-5.34)<0.001
GDF-15/hepcidin ratio483.96 (6.04-4807.2)121.62 (0.21-34398.3)1.77(0.63-6.78)<0.001
GDF-15/EPO ratio310.86 (42.09-4609.2)★,●83.04 (6.0-1002.3)27.08(3.89-138.85)<0.001
GDF-15/sTfR ratio1257.62 (94.8-4609.2)★,●420.6 (0.87-4136.87)0.64(18.33-330.18)<0.001
ERFE(ng/mL)0.324(0.156-20.826)0.379(0.156-2.067)0.843(0.156-4.774)0.027
Hepcidin/ERFE ratio43.51(1.97-989.49)38.08 (3.13-524.26-0.319)136.06(14.90-963.76)0.031
EPO/ERFE ratio98.47(0.88-368.71)★●150.03(27.61-33718.6)8.28(1.35-49.04)0.003
ERFE/sTfR ratio0.04(0.018-3.132)0.054(0.019-0.252)0.39(0.037-7.589<0.001
ERFE/GDF15 ratio0.00003(0.0000095-0.0055)★●0.00007(0.0000069-0.256)0.0055(0.00029-0.025)<0.001

Significant difference between EMH (+), EMH (-), and normal controls: significant difference when compared to normal controls; significant difference when compared to EMH (-).